share_log

Exas Science Shares Are Trading Higher After the Company Announced Data for Its Blood-based Colorectal Cancer Screening Test.

Exas Science Shares Are Trading Higher After the Company Announced Data for Its Blood-based Colorectal Cancer Screening Test.

Exas科學公司宣佈其基於血液的結直腸癌篩查測試數據後,其股價上漲。
Benzinga ·  09/16 07:37

Exas Science Shares Are Trading Higher After the Company Announced Data for Its Blood-based Colorectal Cancer Screening Test.

Exas科學公司宣佈其基於血液的結直腸癌篩查測試數據後,其股價上漲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論